Endo to Acquire Qualitest and Expand its Generics Portfolio
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 8 (Table of Contents)
Published: 27 Oct-2010
DOI: 10.3833/pdr.v2010.i8.1394 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Qualitest Pharmaceuticals, the sixth largest generics company in the US as measured by prescriptions filled, is being acquired by Endo Pharmaceuticals in a cash deal worth US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018